The effects of brain-derived neurotrophic factor on insulin signal transduction in the liver of diabetic mice

82Citations
Citations of this article
69Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aim/hypothesis. We previously reported that repeated subcutaneous or intracerebroventricular injection of brain-derived neurotrophic factor (BDNF) reduces blood glucose concentrations in obese diabetic C57BL/KsJ-db/db mice. In this study, we assessed the effects of BDNF on insulin action in peripheral tissues of diabetic mice. Methods. First, brain-derived neurotrophic factor (20 mg/kg) was subcutaneously given to male db/db mice for 14 days and then the insulin-stimulated tyrosine phosphorylation of insulin receptors and insulin-stimulated phosphatidylinositol (PI) 3-kinase activity in peripheral tissues was assessed. Second, we examined the effects of a single subcutaneous or intracerebroventricular brain-derived neurotrophic factor injection on insulin responsiveness in liver and skeletal muscle of streptozotocin (STZ)-induced diabetic mice. Third, the effects of brain-derived neurothrophic factor on insulin action were also examined in cultured cells. Results. Repeated injection of BDNF to db/db mice for 14 days enhanced insulin-stimulated tyrosine phosphorylation of insulin receptors in liver and insulin-stimulated PI 3-kinase activity in liver, skeletal muscle and interscapular brown adipose tissue. We then examined the rapid effect of BDNF on insulin signalling in vivo. A single subcutaneous or intracerebroventricular injection of BDNF rapidly increased insulin-stimulated tyrosine phosphorylation of insulin receptors and PI 3-kinase activity in liver of STZ-mice. No direct effect of brain-derived neurothrophic factor was observed on insulin signalling in primary cultured hepatocytes, L6 muscle cells or 3T3-L1 adipocytes. Brain-derived neurothrophic factor did not affect either glucose uptake or gluconeogenesis in these cells. Conclusion/interpretation. These data indicate that brain-derived neurothrophic factor rapidly enhances insulin signal transduction in liver and shows hypoglycaemic action in diabetic mice.

References Powered by Scopus

Preparation of Isolated Rat Liver Cells

5374Citations
N/AReaders
Get full text

Physiology of the neurotrophins

1828Citations
N/AReaders
Get full text

Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction

1118Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase

574Citations
N/AReaders
Get full text

BDNF mediates adaptive brain and body responses to energetic challenges

474Citations
N/AReaders
Get full text

The lighter side of BDNF

257Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Tsuchida, A., Nakagawa, T., Itakura, Y., Ichihara, J., Ogawa, W., Kasuga, M., … Noguchi, H. (2001). The effects of brain-derived neurotrophic factor on insulin signal transduction in the liver of diabetic mice. Diabetologia, 44(5), 555–566. https://doi.org/10.1007/s001250051661

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 25

56%

Researcher 11

24%

Professor / Associate Prof. 6

13%

Lecturer / Post doc 3

7%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 12

32%

Medicine and Dentistry 10

26%

Biochemistry, Genetics and Molecular Bi... 10

26%

Neuroscience 6

16%

Save time finding and organizing research with Mendeley

Sign up for free